Skip to main content Help with accessibility Skip to main navigation

BRIMONIDINE TARTRATE Gel (Mirvaso®) for facial erythema of rosacea

CCG Approval Status:

Date Added: 30 - Jan - 2020
Body System:

The Pan Mersey Area Prescribing Committee recommends the prescribing of BRIMONIDINE TARTRATE Gel (Mirvaso®) for the treatment of moderate to severe, persistent facial erythema associated with rosacea in adults